- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
OPPI names Anil Matai as Director General
Anil has functioned on the boards of Zydus Healthcare, Bayer Zydus Pharma, Novartis Healthcare and Biochem Pharmaceutical Industries.
Mumbai: The Organisation of Pharmaceutical Producers of India (OPPI), which represents global research-based pharmaceutical companies, has appointed Anil Matai as its Director General.
Anil Matai, a seasoned general management professional, has extensive experience in the Life Sciences space having worked across MNCs including spearheading operations across Novartis India Ltd, GSK India, and Global Pharma, Dubai. After superannuating as Managing Director of Zydus Healthcare Ltd, Anil was engaged as Senior Advisor - Life Sciences at IQVIA Consulting and Information Services India Pvt. Ltd., and most recently as Operating Partner at Jashvik Capital - a mid-market Private Equity Fund focused on Healthcare & Consumer sector.
Anil has functioned on the boards of Zydus Healthcare Ltd., Bayer Zydus Pharma Private Ltd., Novartis Healthcare Private Ltd and Biochem Pharmaceutical Industries Ltd. As an influential leader, his proven skillsets in operations leadership, collaborative working, stakeholder management, have contributed towards market-leading results. He has championed multi-million-dollar businesses and is proficient in unlocking company value by successfully executing growth strategies, institutionalizing controls, and enhancing productivity.
Welcoming Anil as the Director General, Suresh Pattathil, President, OPPI said, “I welcome Anil on board and am confident that with his breadth of experience, we will be able to lead OPPI to achieve its objective of bringing innovative drugs and new therapies for unmet medical needs and drive key advocacy efforts on IP, Innovation, Quality and other areas. He has been a strong voice for healthcare transformation in the country and under his leadership we will be able to optimize patient outcomes by creating an environment conducive to innovation and growth, engaging productively with Government stakeholders.”
Speaking on his appointment, Anil Matai said, "I am delighted to be a part of the OPPI family during a pivotal moment for healthcare in our nation. I am happy to say that OPPI’s focus on importance of innovation, digitization and quality to drive impact in healthcare, aligns with the Government’s vision for India@100. OPPI will continue to drive policy and advocacy discussions with the Government and endeavor to work together with various stakeholders on industry-related issues, to implement sustainable and patient centric solutions. I look forward to collaborating with the various stakeholders including the Government, Industry, Academia to make a positive impact on patient well-being; in alignment with OPPI’s vision of “Bharat Ke Liye”. I express my gratitude to the members of OPPI's Executive Committee for entrusting me with this responsibility."
Read also: Allergan MD Suresh Pattathil elected as new President of OPPI
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751